Professional institutions engaged in the field of "prevention and treatment of human papillomavirus infection". "Baidesheng Biology", the full name of Beijing Baidesheng Biotechnology Development Co., Ltd., was formally established in 1999. It was transformed from Baidesheng Energy Technology Co., Ltd., an enterprise run by Chinese Academy of Sciences. At present, it is the governing unit of China Academy of Sciences' science and technology product sales network, and it is under the management committee of China Academy of Sciences' science and technology product sales network. 20 13, "Paterline's application of human papillomavirus infection prevention technology project" won the "Golden Bridge Award of China Technology Market Association" from the Ministry of Science and Technology, which is the highest authoritative award in the national technology market industry. 20 16, Patelline, as "a traditional Chinese medicine preparation for preventing and treating human papillomavirus infection", was included in the promotion project of scientific and technological achievements of traditional Chinese medicine in China, state administration of traditional chinese medicine.
Extended data
Human papillomavirus
Human papillomavirus (HPV) is a kind of HPV A, a spherical DNA virus, which can cause the proliferation of squamous epithelium of human skin and mucosa. Manifested as common warts, genital warts (condyloma acuminatum) and other symptoms. With the rapid increase of the incidence of condyloma acuminatum in sexually transmitted diseases and the increase of cervical cancer and anal cancer, human papillomavirus infection has attracted more and more attention.
20 17, 17,1October 27th, the list of carcinogens published by the International Agency for Research on Cancer of the World Health Organization was preliminarily sorted out for reference. Human papillomavirus 6 and 1 1, human papillomavirus β (except types 5 and 8) and γ are among the three carcinogens.
The infection rate of cutaneous human papillomavirus is very common, such as verruca vulgaris, verruca toes, verruca plana and so on. And the specific infection rate cannot be obtained. It is worth noting that genital warts and cervical cancer are caused by high-risk human papillomavirus infection and low-risk human papillomavirus infection in external genitalia. According to statistics, genital warts caused by human papillomavirus infection account for 20% of sexually transmitted diseases in the world.
With regard to the prevalence of human papillomavirus infection in female reproductive tract, according to the survey conducted by the National Health and Nutrition Research Project of the United States in 2003-2004, the total infection rate of human papillomavirus among people aged 14-59 was 26.8%, so the burden of human papillomavirus infection among women exceeded the previous estimate.